At the 2026 Heart Rhythm Society meeting, researchers unveiled an AI system capable of detecting atrial fibrillation (AF) with over 90% accuracy using ECG analysis. The breakthrough could enable ...
At HRS 2026, Dr. Song Zuo presented evidence that AI can detect atrial fibrillation with over 90% sensitivity, ...
At the Heart Rhythm Society 2026 meeting, researchers presented an AI-powered ECG analysis tool that detects atrial fibrillation (AF) with over 90% accuracy. The system can identify both present and ...
Stanford's Dr. Perez shows Apple Watches detect AFib with 86% accuracy, offering accessible cardiac monitoring as 115M ...
Following its successful contribution to the American Association of Equine Practitioners-led project focused on locomotion ...
Please provide your email address to receive an email when new articles are posted on . Two studies found that mass screening for atrial fibrillation in older adults does not reduce stroke. In one ...
Compared with regular checks in primary care, continuous ECG monitoring revealed more asymptomatic older people with hypertension as having atrial fibrillation (Afib), the SCREEN-AF trial showed. The ...
Mass screening for atrial fibrillation using ECG together with heart failure biomarker does not prevent ischaemic stroke or systemic embolism (blood clot) in older adults aged 75-76 years over 5 years ...
The electrocardiogram built into recent Apple Watch models isn’t likely to give wearers false notifications that they have atrial fibrillation, a potentially dangerous heart condition. A clean bill of ...
Garmin has announced a new ECG app for AFibVenu 2 Plus smartwatch users. This app is cleared by the U. S. Food and Drug Administration (FDA) and allows anyone with the Venu 2 Plus to record their ...
On Friday, the Food and Drug Administration granted another 510(k) clearance to iRhythm Technologies for its AI-powered software system designed for use with Verily’s irregular pulse tracking watch.
Screening for atrial fibrillation (Afib) -- whether with ECG in office or via a wearable device -- cannot be recommended for middle age and older adults without symptoms. So reaffirmed the U.S.